LIM
CVS icon

Leavell Investment Management’s CVS Health CVS Stock Holding History

Leavell Investment Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$721K Buy
6,967
+250
+4% +$22.3K 0.03% 372
2026
Q1 		$482K Sell
6,717
-143
-2% -$11K 0.02% 424
2025
Q4 		$544K Sell
6,860
-1,029
-13% -$81.1K 0.02% 390
2025
Q3 		$595K Buy
7,889
+2
+0% +$137 0.03% 379
2025
Q2 		$544K Buy
7,887
+560
+8% +$36.7K 0.02% 388
2025
Q1 		$496K Sell
7,327
-373
-5% -$22.3K 0.02% 382
2024
Q4 		$346K Sell
7,700
-2,263
-23% -$127K 0.02% 442
2024
Q3 		$626K Sell
9,963
-1,478
-13% -$86.2K 0.03% 352
2024
Q2 		$676K Sell
11,441
-2,305
-17% -$144K 0.04% 318
2024
Q1 		$1.1M Buy
13,746
+197
+1% +$15K 0.06% 255
2023
Q4 		$1.07M Sell
13,549
-1,017
-7% -$72.4K 0.07% 249
2023
Q3 		$1.02M Sell
14,566
-324
-2% -$23K 0.07% 243
2023
Q2 		$1.03M Buy
14,890
+200
+1% +$14.2K 0.07% 239
2023
Q1 		$1.09M Sell
14,690
-757
-5% -$63.5K 0.08% 229
2022
Q4 		$1.44M Sell
15,447
-150
-1% -$14.5K 0.11% 190
2022
Q3 		$1.49M Buy
15,597
+1,575
+11% +$156K 0.12% 176
2022
Q2 		$1.3M Buy
14,022
+523
+4% +$51K 0.1% 187
2022
Q1 		$1.37M Buy
13,499
+40
+0.3% +$4.2K 0.09% 195
2021
Q4 		$1.39M Buy
13,459
+650
+5% +$60.1K 0.09% 196
2021
Q3 		$1.09M Buy
12,809
+1,841
+17% +$154K 0.08% 210
2021
Q2 		$825K Hold
10,968
– – 0.07% 225
2021
Q1 		$825K Buy
10,968
+253
+2% +$18.4K 0.07% 225
2020
Q4 		$732K Sell
10,715
-250
-2% -$16.3K 0.06% 231
2020
Q3 		$640K Buy
10,965
+554
+5% +$34.5K 0.06% 235
2020
Q2 		$676K Buy
10,411
+866
+9% +$54.5K 0.07% 218
2020
Q1 		$566K Sell
9,545
-127
-1% -$8.48K 0.07% 212
2019
Q4 		$719K Sell
9,672
-109
-1% -$7.65K 0.07% 224
2019
Q3 		$617K Buy
9,781
+1,615
+20% +$95.7K 0.06% 236
2019
Q2 		$445K Buy
8,166
+2,000
+32% +$108K 0.05% 272
2019
Q1 		$333K Sell
6,166
-300
-5% -$18.5K 0.04% 300
2018
Q4 		$424K Sell
6,466
-1,187
-16% -$88.6K 0.05% 260
2018
Q3 		$602K Buy
7,653
+1,146
+18% +$81.9K 0.06% 235
2018
Q2 		$419K Buy
6,507
+754
+13% +$49.7K 0.05% 272
2018
Q1 		$358K Hold
5,753
– – 0.04% 294
2017
Q4 		$417K Hold
5,753
– – 0.05% 279
2017
Q3 		$468K Sell
5,753
-580
-9% -$45.9K 0.06% 257
2017
Q2 		$510K Sell
6,333
-100
-2% -$7.9K 0.06% 245
2017
Q1 		$505K Buy
6,433
+200
+3% +$16K 0.06% 238
2016
Q4 		$492K Sell
6,233
-18,933
-75% -$1.53M 0.07% 238
2016
Q3 		$2.24M Sell
25,166
-3,000
-11% -$283K 0.33% 95
2016
Q2 		$2.7M Sell
28,166
-1,134
-4% -$113K 0.4% 73
2016
Q1 		$3.04M Buy
29,300
+958
+3% +$93.2K 0.46% 63
2015
Q4 		$2.77M Buy
28,342
+1,809
+7% +$177K 0.41% 69
2015
Q3 		$2.56M Buy
26,533
+3,376
+15% +$355K 0.4% 71
2015
Q2 		$2.43M Buy
23,157
+5,200
+29% +$531K 0.38% 82
2015
Q1 		$1.85M Buy
17,957
+1,000
+6% +$101K 0.28% 110
2014
Q4 		$1.63M Buy
16,957
+3,272
+24% +$288K 0.25% 122
2014
Q3 		$1.09M Hold
13,685
– – 0.17% 158
2014
Q2 		$1.03M Buy
13,685
+1,000
+8% +$75.6K 0.16% 164
2014
Q1 		$950K Buy
12,685
+5,302
+72% +$375K 0.16% 164
2013
Q4 		$528K Hold
7,383
– – 0.09% 211
2013
Q3 		$419K Buy
7,383
+300
+4% +$17.9K 0.08% 238
2013
Q2 		$405K Buy
+7,083
New +$410K 0.08% 234

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Leavell Investment Management's CVS Position: Q2 2026 in Review

Leavell Investment Management increased its CVS Health (CVS) stake by 3.7% in Q2 2026, buying an estimated $22.3K and bringing the position to 6,967 shares worth $721K. The position accounts for 0.03% of the portfolio, ranked #372.

Leavell Investment Management first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.04M in Q1 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Leavell Investment Management held 6,967 shares of CVS Health worth $721K as of Q2 2026.
  • Leavell Investment Management bought 250 CVS Health shares in Q2 2026, an estimated $22.3K.
  • CVS Health made up 0.03% of Leavell Investment Management's portfolio in Q2 2026, its #372 holding.
  • Leavell Investment Management first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Leavell Investment Management's CVS Health position peaked at $3.04M in Q1 2016.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.